(Q50995133)

English

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.

scientific article published on 26 March 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

title

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

0 references

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

Olga Borges

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

Teresa Gonçalves

object named as

T Gonçalves

series ordinal

3

0 references

author name string

D Bento

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

language of work or name

English

0 references

publication date

26 March 2015

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

published in

European Journal of Pharmaceutics and Biopharmaceutics

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

volume

93

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

page(s)

149-164

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

Identifiers

DOI

10.1016/J.EJPB.2015.03.024

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

PubMed publication ID

25818119

1 reference

stated in

Europe PubMed Central

PubMed publication ID

25818119

retrieved

26 March 2018

reference URL

http://europepmc.org/abstract/MED/25818119

(Q50995133)

Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)